AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Heamclas-FCM Injection

Prescription Icon
Prescription Required

Marketer

Gleason Healthcare

Salt Composition

Ferric Carboxymaltose (50mg/ml)

Overview Heamclas-FCM Injection

Ferinject-FCM injection replenishes iron levels in the body. It's indicated for treating iron-deficiency anemia, a condition characterized by low red blood cell counts stemming from insufficient iron. Red blood cells, crucial for oxygen transport, require iron for their production. Administered intravenously by a healthcare professional, either as an injection or infusion, Ferinject-FCM requires close monitoring for allergic reactions. Typically, two doses are given a week apart, with dosage and frequency determined by your physician based on your anemia's severity. A balanced diet rich in iron, vitamins, and minerals is recommended to support iron replenishment. Excellent iron sources include meat, eggs, dried fruit, leafy greens, and legumes. Common, generally transient, side effects include nausea, headache, lightheadedness, elevated blood pressure, and injection site discomfort. Persistent or bothersome side effects warrant medical attention. This medication is unsuitable for anemias not stemming from iron deficiency. Pre-treatment disclosure of rheumatoid arthritis, asthma or other allergies, hypertension, or liver conditions is crucial. Pregnancy and breastfeeding safety haven't been established; seek medical counsel. Regular blood tests will track blood counts, iron levels, treatment progress, and potential side effects. Moderating alcohol consumption during treatment is advisable.

Uses of Heamclas-FCM Injection

Managing iron-deficiency anemia

Major Benefits of Heamclas-FCM Injection:

The medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Heamclas-FCM Injection:

  • Headache
  • Dizziness
  • High blood pressure
  • Injection site reactions (pain, swelling, redness)
  • Vomiting
  • Nausea
  • Dark colored stool

How to use Heamclas-FCM Injection:

This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.

How Heamclas-FCM Injection works:

Ferumoxytol injection (Heamclas-FCM) treats iron deficiency anemia by restoring depleted iron levels. This is crucial because iron is essential for producing red blood cells and hemoglobin, the oxygen-carrying component of these cells.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Heamclas-FCM Injection hasn't been established as safe. Seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Heamclas-FCM Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Heamclas-FCM Injection poses no known breastfeeding safety risk. Research in humans indicates minimal to negligible drug transfer into breast milk, presenting no apparent harm to infants.

DrivingDrivingSAFE

Driving ability is typically unaffected by Heamclas-FCM Injection.

KidneyKidneySAFE IF PRESCRIBED

Heamclas-FCM Injection appears safe for individuals with kidney impairment. Preliminary evidence indicates dose modification may be unnecessary for this patient group. Physician consultation is recommended.

LiverLiverCAUTION

For individuals with hepatic impairment, Heamclas-FCM Injection requires careful administration. Dosage modification of Heamclas-FCM Injection might be necessary. Physician consultation is advised.

What if you forget to take Heamclas-FCM Injection :

Should you forget a scheduled dose of Heamclas-FCM Injection, seek your physician's advice.

Facts to Know About Heamclas-FCM Injection

LabelValue
Chemical Category Iron-Carbohydrate Compound
Developing Habits No.
Type of Therapy OBSTETRICS AND GYNECOLOGY

FAQs on Heamclas-FCM Injection

Trained personnel, capable of managing anaphylaxis, should administer Heamclas-FCM Injection. This injection may be given undiluted intravenously, via a dialyzer (if applicable), or as a sodium chloride dilution administered intravenously. Post-injection monitoring should continue for at least 30 minutes. Subcutaneous or intramuscular administration is contraindicated.
Store Heamclas-FCM injection vials between 20°C and 25°C (68°F and 77°F). Do not freeze. Temperature fluctuations should remain within 15°C to 30°C (59°F to 86°F).
This medication is typically administered in two doses, seven days apart. Hemoglobin levels are checked at least four weeks after the second dose to monitor red blood cell production. Further treatment may be necessary if iron deficiency persists.
Heamclas-FCM Injection can temporarily raise blood pressure, sometimes causing facial flushing, dizziness, and nausea. These side effects usually begin immediately after injection and subside within 30 minutes.
Heamclas-FCM Injection leakage at the injection site may occur with improper administration. Stop administration immediately if leakage is observed, as this can lead to skin irritation and persistent brown skin discoloration.
Insufficient data exists regarding Heamclas-FCM Injection use during pregnancy. Inform your doctor about your pregnancy or pregnancy plans. If you conceive while using Heamclas-FCM Injection, consult your doctor immediately to determine whether treatment should continue.
Heamclas-FCM Injection
2,380
MRP 2,900
17% off